B6.046 Research Ethics: MS Flashcards
phase 0
exploring if the drug may work
- exploratory studies
- few small doses in a few patients
phase 1
is it safe?
- usually first that involve people
- small #s 20-80 people
phase 2
does the treatment work?
- 50-100s of patients
- gets better idea of efficacy and effects in the short term
phase 3
is it better than what’s available?
- compare against current standard
- large group of patients who are ill to look for statistical significance
phase 4
post marketing surveillance
-reports back about positive and negative effects
function of IRB
ensure research studies involving human subjects are scientifically justified
assess safety and risk/benefit ratio
protects subjects rights to:
-privacy
-right to voluntary informed consent before participation
-right to withdraw at any time
how to determine scientific merit?
appropriate scientific basis in lab and animal studies
plausible scientific justification for use in humans
background about risks - lit review, tox studies
equipoise
reasonable clinician would say that the current investigational approach may or may not be better than the comparison
steps in the research process
recruitment of subjects?
how will consent be obtained?
protection of privacy?
how will subjects be protected from other risks of the research intervention?
will individual test results be returned to subjects during the study?
will findings be shared with participants?
preconditions of informed consent
decision making capacity
voluntariness
information that must be conveyed in informed consent
nature of proposed intervention
risks of the intervention, risks of the disease without intervention, and known, serious possible complications
expected benefits of the intervention
alternatives, including of doing nothing
standard for disclosure in informed consent
what would a reasonable patient want to know?
in some states can use what a reasonable provider would disclose
patient decision in informed consent
communication
documentation
what is a COI
professional judgement or actions could be influenced by a private or personal interest, resulting in personal, financial, or professional gain
participant safety may be influenced by a tendency on the part of the investigator to want a favorable outcome
types of COI
financial non financiak: personal professional institutional perceived